Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-07
2006-11-07
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S443000, C514S469000, C514S471000, C549S058000, C549S077000, C549S469000, C549S494000
Reexamination Certificate
active
07132445
ABSTRACT:
There are disclosed compounds of the formulaor a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.
REFERENCES:
patent: 4170588 (1979-10-01), Hegenberg et al.
patent: 4639523 (1987-01-01), Nohara et al.
patent: 5206252 (1993-04-01), Butera et al.
patent: 5354763 (1994-10-01), Butera et al.
patent: 5397790 (1995-03-01), Butera et al.
patent: 5401753 (1995-03-01), Butera et al.
patent: 5403853 (1995-04-01), Butera et al.
patent: 5466712 (1995-11-01), Butera et al.
patent: 5506252 (1996-04-01), Butera et al.
patent: 5532245 (1996-07-01), Butera et al.
patent: 5840764 (1998-11-01), Quagliato et al.
patent: 5962535 (1999-10-01), Miyamoto et al.
patent: 6300325 (2001-10-01), Widdowson et al.
patent: 6376555 (2002-04-01), Butera et al.
patent: 6420396 (2002-07-01), Albers et al.
patent: 2001/0018447 (2001-08-01), Widdowson et al.
patent: 2003/0204085 (2003-10-01), Taveras et al.
patent: 2004/0034229 (2004-02-01), Taveras et al.
patent: 33 09 655 (1984-09-01), None
patent: 0 275 997 (1988-07-01), None
patent: 0 376 079 (1990-07-01), None
patent: 0 796 243 (1999-01-01), None
patent: 1186096 (1970-04-01), None
patent: WO 94/29277 (1994-12-01), None
patent: WO 95/14005 (1995-05-01), None
patent: WO 96/14300 (1996-05-01), None
patent: WO 96/15103 (1996-05-01), None
patent: WO 98/33763 (1998-08-01), None
patent: WO 00/20378 (2000-04-01), None
patent: WO 00/21927 (2000-04-01), None
patent: WO 00/35855 (2000-06-01), None
patent: WO 00/35864 (2000-06-01), None
patent: WO 00/73260 (2000-12-01), None
patent: WO 01/29000 (2001-04-01), None
patent: WO 01/64208 (2001-09-01), None
patent: WO 01/64691 (2001-09-01), None
patent: WO 01/68569 (2001-09-01), None
patent: WO 01/92202 (2001-12-01), None
patent: WO 02/057230 (2002-07-01), None
patent: WO 02/067919 (2002-09-01), None
patent: WO 02/076926 (2002-10-01), None
patent: WO 02/083624 (2002-10-01), None
patent: WO 03/080053 (2003-10-01), None
patent: WO 05/075447 (2005-08-01), None
Communication pursuant to Article 96(2) EPC for Appl. No. 02 739 172.1-2101, dated Jul. 13, 2004.
Communication pursuant to Article 96(2) EPC for Appl. No. 03 772 075.2-2101. dated Nov. 14, 2005.
Translation for Japanese 6-92915 (See Reference CA on Applicants' 1449 Form Filed Apr. 12, 2004), 1994.
Esp@cenet Document, “1,2,5-Thiadiazole-1-oixdes and 1,1-dioxides, process for their preparation and their use as medicaments” (for DE3309655 which is attached to said esp document),2004.
Chemical Abstract 66:18527 for Maahs, Guenther, et al., “Syntheses and derivatives of squaric acid,”Angewandte Chemie78(20):927-31 (1966) (which is attached to said abstract).
Chemical Abstract 87:134383 for Augustin Manfred, et al., “Disubstitution in 2,3-dichloromaleimides”Zeitschrift FuerChemie 17(6):215-216 (1977) (which is attached to said abstract).
Chemical Abstract No. 87:151727 for Ehrhardt, Heinz, et al., “Amides and thioamides of squaric acid: syntheses and reactions,”Chemische Berichte110(7):2506-23 (1977) (which is attached to said abstract).
Chemical Abstract 104:129517 for Gruenefeld, Johann, et al., “Reactions of squaric acid with carbodiimides,”Archiv der Pharmazie318(12):1062-70 (1985) (which is attached to said abstract).
Chemical Abstract No. 122:160745 for Tillack, Annegret, et al., “Assymmetric catalysis. IV. Hydrosilylation of acetophenone with pyrroline-2,5-dione modified [Rh(COD)C1]2 catalyst,”Journal of Organometallic Chemistry482:84-91 (1994) (which is attached to said abstract).
Chemical Abstract No. 125:300482 for Chen, Yizhao, et al., “Reaction of dibutyl oxosquarate with aromatic primary amines,”Sichuan Daxue Xuebao, Ziran Kexueban33(2): 182-186 (1996) (which is attached to said abstract).
Chemical Abstract No. 130:222994 for Chen, Yi-Zhao, et al., “Synthesis of asymmetric aryl-substituted amides of squaric acid and asymmetric isosquarylium amides,”Hechen Huaxue6(4):383-392 (1998) (which is attached to said abstract).
Butera, John A., et al., “Design and SAR of Novel Potassium Channel Openers Targeted for Urge Urinary Incontinence. 1.N-Cyanoguanidine Bioisosteres Possessing in Vivo Bladder Selectivity,”J. Med. Chem. 43:1187-1202 (2000).
Davis, Peter D., et al., “Inhibitors of protein kinase C 1. 2,3-Bisarylmaleimides,”J. Med. Chem. 35:177-184 (1992).
Hanaineh-Abdelnour, Leila, et al., “Some synthetic applications of 2,3-Dichloro-N-phenylmaleimide: A Novel Synthesis of 2-Phenylpyrrolo[3,4-b]quinoxaline-1,3-diones. I,”Tetrahedron55: 11859-11870 (1999).
Neuse, Eberhard W., et al., “Poly(squaryl amides)”Polymer15:339-45 (1974).
Patent Abstracts of Japan, vol. 018, No. 361 (c-1222), Jul. 7, 1994 and JP 06 092915A, Apr. 5, 1994 abstract.
Zhou, Hai-Bing, et al., “Design, synthesis and structure of new chiral squaric acid monoaminoalcohls and diaminoalcohols and their use as catalysts in asymmetric reduction of ketones and diketones,”Tetrahedron57:9325-9333 (2001).
U.S. Appl. No. 10/335,789, filed Jan. 2, 2003.
U.S. Appl. No. 10/390,078, filed Mar. 17, 2003.
U.S. Appl. No. 10/680,393, filed Oct. 7, 2003.
PCT International Search Report dated Aug. 2, 2002 for related PCT Application No. PCT/US02/12681.
PCT International Search Report dated Nov. 17, 2003 for related PCT Application No. PCT/US03/23722.
PCT International Search Report dated Nov. 17, 2003 for related PCT Application No. PCT/US03/23785.
Aki Cynthia J.
Baldwin John J.
Biju Purakkattle J.
Bond Richard W.
Chao Jianhua
Freistein Andrew B.
Jeanettte Henry C.
McKane Joseph K.
Pharmacopeia Drug Discovery Inc.
Schering Corporation
LandOfFree
3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3701034